INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

Rhythm Pharmaceuticals’ obesity drug cuts BMI by up to 18.8% in two-year trial

Save Like Comments Compare coverage
Image from The Hindu

Summary

Long-term trial findings presented at ObesityWeek 2026 showed sustained reductions in body mass index among patients receiving the therapy.

Description from The Hindu.

Who is covering this

  1. The Hindu Leans left Factuality: High IN
    Rhythm Pharmaceuticals’ obesity drug cuts BMI by up to 18.8% in two-year trial

    Long-term trial findings presented at ObesityWeek 2026 showed sustained reductions in body mass index among patients receiving the therapy.

Comments

Comments need JavaScript.